Citius Oncology, Inc.
CTOR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,997 | -$5 | -$8 | -$6,659 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $274 | $0 | $0 | $264 |
| Stock-Based Comp. | $0 | $2 | $2 | $1,808 |
| Change in WC | -$2,953 | $2 | $4 | $4,586 |
| Other Non-Cash | $2,140 | $1 | $2 | $0 |
| Operating Cash Flow | -$5,535 | $0 | $0 | $0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$5,795 | $0 | $0 | $0 |
| Investing Cash Flow | -$5,795 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $15,285 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $15,285 | $0 | $0 | $0 |
| Forex Effect | -$31 | $0 | $0 | $0 |
| Net Chg. in Cash | $3,925 | $0 | $0 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $0 | $0 |
| End Cash | $3,925 | $0 | $0 | $0 |
| Free Cash Flow | -$5,535 | $0 | $0 | $0 |